GENSPEED Superbug CR is a rapid molecular diagnostic test designed for the quick identification of antibiotic-resistant bacteria, specifically those producing carbapenemase. Developed by Genspeed Biotech, this system is a critical tool for Hospital Acquired Infection (HAI) surveillance.
Key Features and Capabilities
- Detection Capability: It identifies more than 70 carbapenemase variants in a single multiplexed test, including major resistance genes such as blaKPC, blaVIM, blaNDM, and blaOXA-48.
- Sample Types: Validated for use with stool samples and rectal swabs, allowing for direct testing from clinical specimens without the need for prior cultivation.
- Turnaround Time: Provides results in under 100 minutes, significantly faster than traditional culture-based methods.
- Technology: Uses the proprietary GENSPEED technology, which combines microfluidics and miniaturized optical detection (lab-on-a-chip) for high specificity and sensitivity.
Manufacturer: GENSPEED Biotech GmbH
Addresses:
- Gewerbepark 2 • Gebäude B, 4261 Rainbach, Austria
- Phone: +43 7942 20910 or +43 664 81 92 993
Product Prices:
Genspeed Biotech does not publicly list specific prices for the GENSPEED Superbug CR test or the accompanying R2 analyzer on its website; pricing is typically determined through direct negotiations with distributors and depends on the order volume.
Free References
ISMD2016 Eleventh International Symposium on Molecular Diagnostics
Leave a Reply